Alumis, Inc. (ALMS)
5.60
-0.53
(-8.65%)
USD |
NASDAQ |
Nov 13, 16:00
5.55
-0.05
(-0.89%)
After-Hours: 19:59
Alumis Total Liabilities (Quarterly) : 110.29M for Sept. 30, 2026
Total Liabilities (Quarterly) Chart
Historical Total Liabilities (Quarterly) Data
| Date | Value |
|---|---|
| September 30, 2026 | 110.29M |
| June 30, 2026 | 108.46M |
| March 31, 2026 | 104.57M |
| December 31, 2025 | 114.84M |
| September 30, 2025 | 103.24M |
| June 30, 2025 | 125.60M |
| Date | Value |
|---|---|
| March 31, 2025 | 92.98M |
| December 31, 2024 | 80.89M |
| September 30, 2024 | 64.17M |
| June 30, 2024 | 64.70M |
| March 31, 2024 | 67.73M |
| December 31, 2023 | 53.50M |
Total Liabilities Definition
Liabilities are a main portion of the balance sheet of a company that measure outstanding payables/obligations. A few examples of liabilties of a company include accounts payable, current debt, and capital lease obligations. From an accounting perspective, the balance sheet equation is Liabilties = Assets - Shareholder's Equity.
Total Liabilities (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Total Liabilities (Quarterly) Benchmarks
| Johnson & Johnson | 115.90B |
| BioAge Labs, Inc. | 21.20M |
| ANI Pharmaceuticals, Inc. | 930.55M |
| Corcept Therapeutics, Inc. | 200.29M |
| Veru, Inc. | 8.651M |
Total Liabilities (Quarterly) Related Metrics
| Total Assets (Quarterly) | 488.71M |
| Shareholders Equity (Quarterly) | 378.42M |
| Debt to Equity Ratio | 0.0933 |
| Current Ratio | 5.574 |
| Net Debt Paydown Yield | 0.07% |